After axing a wide swath of federal research projects and grants, a recent slew of awards offers a glimpse into the kinds of science the second Trump administration wants to back: in vivo cell ...
The U.S. government has awarded Kernal Bio and three other sub-awardees up to $48 million to help advance the biotech’s in vivo mRNA-encoded CAR T-cell program. In an interesting—if not somewhat ...
Goal of POSEIDON is to enable accurate, low-cost, accessible cancer screening for all Americans Program to deliver first-in-class synthetic-sensor based MCED test for Stage I detection of 30+ solid ...
Funds will advance Kernal Bio’s in vivo CAR T-cell therapy program and expand the capabilities of its mRNA 2.0 platform Program aims to improve cancer care by increasing the accessibility of advanced ...
Kernal Biologics, Inc., a venture-backed TechBio company pioneering novel therapeutics to program human cells directly inside the body, today announced that it has been awarded up to $48 million in ...
Late last year, the Geneva City Council awarded American Rescue Plan Act funds in economic incentive agreements with the owner of 214-218 W. State St. and 220-222 West State St. In two unanimous votes ...
The Amazon helps stabilize the global climate and is home to more than 40 million people and around 10% of the world’s known species. To protect the world’s largest tropical rain forest, Brazil ...
Arthrosi Therapeutics has secured a nine-figure funding round to accelerate development of a new kind of gout medicine. The San Diego-based biotechnology startup on Wednesday revealed it has closed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback